As winter approaches and cases of COVID-19 increase, pharmacy owners may want to consider provision and promotion of the COVID-19 Lateral Flow Device (LFD) service. While this service is available throughout the year, pharmacy teams may start to see more patients asking about the availability of the service and consideration could be given to highlighting [...]
The post LFD service: Are you providing it? appeared first on Community Pharmacy England.
Community Pharmacy England will be holding a webinar about the new hub and spoke dispensing regulations on Wednesday 29th October at 7pm. Regulations permitting hub and spoke dispensing between different retail pharmacy business came into effect earlier this month The new provisions enable all pharmacies to have hub and spoke arrangements, subject to certain requirements [...]
The post Webinar: Hub and spoke update appeared first on Community Pharmacy England.
With negotiations on the 2026/27 Community Pharmacy Contractual Framework (CPCF) expected to begin this autumn, Community Pharmacy England CEO Janet Morrison gave an important sector update at this week’s Pharmacy Show. Janet outlined how Community Pharmacy England has been preparing for the upcoming CPCF negotiations and working to drive better outcomes for the sector. Drawing [...]
The post Pharmacy Show hears about work to drive better outcomes for sector appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Dalivit® Oral Drops MSN/2025/055 Tier 2 – medium impact Date of issue: 15/10/2025 Dalivit® Oral Drops are out of stock until further notice. Abidec® Multivitamin Drops remain available and can support increased demand. A copy of this [...]
The post Medicine Supply Notification: Dalivit® Oral Drops appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]
The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.
Recent Comments